IRCT20201108049309N1CompletedPhase 3
Evaluation of the effectiveness of Metformin in comparison with Doxycycline in treatment of patients with Acne Vulgaris skin disease.
Conditions
Trial Snapshot
- Phase
- Phase 3
- Status
- Completed
- Enrollment
- 40
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 16 years to 40 years (—)
- Sex
- All
Inclusion Criteria
- •16-40 years old patients with moderate acne .
- •They should not have been treated with systemic medications since 1 month ago.
- •They should not have been treated with topical therapy since 2 weeks ago.
Exclusion Criteria
- •The patients with a history of hypersensitivity to metformin and doxycycline. . Patients with systemic diseases are excluded.
- •The patients with systemic disease
- •The pregnant and lactating women
Investigators
Similar Trials
Not yet recruiting
Phase 2
Metformin in the prevention of preeclampsiaPre-eclampsiapreeclampsia.IRCT20230730058975N1Esfahan University of Medical Sciences160
Recruiting
Phase 2
An assessment of the use of metformin in preventing prednisone-induced elevation in blood glucose levels among blood cancer patients at Kenyatta National HospitalPACTR201807745027158ucy Ochola50
Recruiting
Phase 3
Evaluation of the effectiveness of metformin in WOMAC index of overweight knee osteoarthritis patientsOsteoarthritis.Osteoarthritis of kneeIRCT20200522047538N2Mashhad University of Medical Sciences88
Recruiting
Phase 3
Evaluation of the effectiveness of metformin prophylaxis in preventing risperidone-induced hyperprolactinemia in children and adolescentsHyperprolactinemiaIRCT20200304046698N2Shahid Beheshti University of Medical Sciences40
Recruiting
Phase 2
Evaluation of the effectiveness of Metformin and Curcumin in pcosPolycystic Ovarian Syndrom.Endocrine, nutritional and metabolic diseasesIRCT20221117056528N1Zahedan University of Medical Sciences200